Progressive and chronic airway inflammation and infection are hallmarks of cystic fibrosis (CF) lung disease. A reduction of the host inflammatory response could favorably modify the disease phenotype. Indeed this has been the goal of clinical trials with steroids and non-steroidal anti-inflammatory drugs. Another approach to reduce inflammation is to silence pro-inflammatory mediators by RNA interference (RNAi). Here, we propose to use several novel methods to accomplish RNAi in the airways. In one approach, we hypothesize that virally expressed inhibitory RNAs can effectively transduce airway epithelia and inhibit expression of our target genes. We will use methods developed in our laboratories for optimal inhibitory RNA expression. In a second approach, we will use peptide-siRNA complexes. In these experiments, we will take advantage of peptides that bind to airway epithelia to direct siRNA uptake and target gene silencing. For both viral and nonviral experiments, we will first test the effectiveness in vitro using well differentiated airway epithelia. Once optimized in vitro, the tools will be tested in vivo in wild type, and then CF pigs. Importantly, the methods we develop to deliver RNAi and reduce geneexpression in vitro and in vivo will have direct relevance to other pro-inflammatory targets, and newly identified participants in CF ainway disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL051670-20
Application #
8519509
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
20
Fiscal Year
2013
Total Cost
$269,974
Indirect Cost
$88,993
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Park, Jung-Eun; Li, Kun; Barlan, Arlene et al. (2016) Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism. Proc Natl Acad Sci U S A 113:12262-12267
Cooney, Ashley L; Abou Alaiwa, Mahmoud H; Shah, Viral S et al. (2016) Lentiviral-mediated phenotypic correction of cystic fibrosis pigs. JCI Insight 1:
Gibson-Corley, Katherine N; Meyerholz, David K; Engelhardt, John F (2016) Pancreatic pathophysiology in cystic fibrosis. J Pathol 238:311-20
Steines, Benjamin; Dickey, David D; Bergen, Jamie et al. (2016) CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes. JCI Insight 1:e88728
Li, Xiaopeng; Tang, Xiao Xiao; Vargas Buonfiglio, Luis G et al. (2016) Electrolyte transport properties in distal small airways from cystic fibrosis pigs with implications for host defense. Am J Physiol Lung Cell Mol Physiol 310:L670-9
Hisert, Katherine B; Schoenfelt, Kelly Q; Cooke, Gordon et al. (2016) Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis. Am J Respir Cell Mol Biol 54:594-7
Shah, Viral S; Meyerholz, David K; Tang, Xiao Xiao et al. (2016) Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science 351:503-7
Tang, Xiao Xiao; Ostedgaard, Lynda S; Hoegger, Mark J et al. (2016) Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J Clin Invest 126:879-91
Cook, Daniel P; Rector, Michael V; Bouzek, Drake C et al. (2016) Cystic Fibrosis Transmembrane Conductance Regulator in Sarcoplasmic Reticulum of Airway Smooth Muscle. Implications for Airway Contractility. Am J Respir Crit Care Med 193:417-26
Meyerholz, David K; Lambertz, Allyn M; McCray Jr, Paul B (2016) Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome. Am J Pathol 186:78-86

Showing the most recent 10 out of 148 publications